The healthcare buyer of multilingual services is rarely buying just translation or just interpretation. They are buying a documented chain of controls that maps to a procurement audit, a clinical risk review, and a payer or regulator audit. Below is what that chain typically needs to cover and where most vendors leave gaps.
The four frameworks usually in scope
For US healthcare programs reaching language-other-than-English populations, the four frameworks that show up in procurement most often are:
- HIPAA / HITECH for any interpretation session, transcription, or translation that touches PHI. A Business Associate Agreement (BAA) is the operative document, not the marketing claim.
- ADA Title III for communication access — covers sign language interpretation, CART captioning, and accessible-format translation.
- Section 1557 of the ACA for any federally-funded health program. Requires meaningful access for limited-English-proficient patients; includes specific notice and tagline requirements.
- Joint Commission language access standards for accredited hospital systems. These require qualified interpretation, not just bilingual staff acting informally.
The four overlap but are not identical. A vendor scope that names “HIPAA-aligned handling” and leaves the others unstated is a partial answer.
What a complete scope return should name
For a healthcare translation or interpretation engagement, a clean scope return includes:
- Which standards apply to which deliverables. Translation production runs under ISO 17100:2015. Information security applies under ISO 27001:2022. Interpretation does not have its own ISO production standard in the same way translation does — naming this clearly matters.
- BAA execution timing. Before any session that touches PHI, the BAA needs to be countersigned. Some vendors handle this in 2-3 days; some require multiple legal cycles. Procurement should know which.
- Interpreter qualification documentation. Joint Commission and Section 1557 expect “qualified” interpreters. Qualification is documented through training records, language-proficiency assessment, and medical-terminology coursework. A scope return should name the qualification framework — CCHI, NBCMI, or equivalent — for medical interpretation.
- Trauma-informed and gendered-pairing protocols. For asylum-related medical work, OB-GYN, and women’s-health contexts, pairing protocols matter. Default expectations should be in scope, not requested later.
- Audit trail format. What QA log ships with the deliverable. What edit history is retained. How long records are kept and under what controls.
Where most vendors leave gaps
The recurring gaps observed in procurement reviews:
- Vendors who hold ISO 17100 but apply it to interpretation work as if it covered them. It does not. ISO 17100 is a translation production standard.
- Vendors who claim HIPAA compliance without providing a BAA on request. Compliance claim without a counterparty document is unenforceable.
- Vendors whose Section 1557 tagline translations are mass-produced and not reviewed against the specific health system’s brand and approved terminology. The taglines look right but fail brand review on production.
- Vendors who do not maintain credentialing files on individual interpreters and cannot produce them under audit.
These gaps usually don’t surface until audit time. Surface them at scope.
The simplest test
Ask a prospective vendor three questions on a procurement call:
- Can you send a sample BAA today?
- Which ISO standard applies to interpretation work in your delivery model?
- Show me a sample QA log from a completed engagement (redacted).
A vendor who answers all three crisply is operating a real compliance chain. A vendor who deflects any one of them is selling marketing claims.
For programs that need this chain documented at scope rather than discovered later, send a brief and we will return a scope with the controls named per deliverable.